| abstract |
Antisense compounds, compositions, and methods are provided that modulate the expression of glutamine-fructose-6-phosphate aminotransferase (GFAT). The composition comprises an antisense compound, particularly an antisense oligonucleotide, that targets a nucleic acid encoding GFAT. Methods are provided for using these compounds to modulate GFAT expression and to treat diseases associated with GFAT expression. |